Stroke
Conditions
Interventions
This is a multicenter, randomized, placebo-controlled, double-blind clinical trial. The individuals will be allocated to three groups, with a random distribution program generated by a computer, using
(N=17). Group 2 – Conventional Group (CG): Transcranial direct current stimulation of the anodic type in the right parietal lobe, anode was placed on P4, and the cathode was placed on the left supraor
(N=17). Group 3 - Sham Group (GS): Transcranial sham direct current stimulation, the stimulator was turned on and the current intensity was gradually increased for 30 s and decreased for 30 s, with sh
E02.621.820
E02.331.750
Sponsors
Departamento de Clinica Médica
Departamento de Clinica Médica
Eligibility
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Individuals of both sexes, aged 18 to 85 years, with a diagnosis of ischemic stroke in the subacute phase (7 days to 3 months from the onset of symptoms, due to lesions of the right virus, confirmed by tomography CT and or magnetic resonance imaging (MRI) and unilateral spatial neglect diagnosed by checking less than 129 on the Behavior Intention Test - BIT
Exclusion criteria
Exclusion criteria: Individuals with any metal in the head segment, skin lesions in the electrode placement area, clinical instability, severe cognitive impairment, global aphasia, visual disturbances prior to stroke, hemorrhagic stroke, previous Rankin bigger then 1, bilateral lesions, pacemaker, epilepsy, severe CHF or unstable conditions that may pose a risk to the participant, concurrent diagnosis of rapidly deteriorating illness (eg, terminal cancer), participating in studies involving medications or other interventions, pregnancy, or other associated neurological conditions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decrease the degree of unilateral spatial neglect after treatment verified by Behavior Inattention Test (BIT), from finding a variation of at least 15% in the pre and post intervention measurements. | — |
Secondary
| Measure | Time frame |
|---|---|
| Decrease the degree of unilateral spatial neglect after treatment verified by Catherine Bergego scale, from finding a variation of at least 15% in the pre and post intervention measurements.;Increasing the degree of autonomy observed with the Barthel index, from the finding of a change of at least 15% in pre and post intervention measurements.;Increasing the functional capacity observed with the modified Rankin scale, from the finding of a change of at least 15% in pre and post intervention measurements.;Decrease in frailty observed with the PRISMA-7 scale, based on the verification of a change of at least 15% in pre- and post-intervention measurements.;Increase in the degree of quality of life verified through the European scale of quality of life, based on the verification of a variation of at least 15% in the pre and post intervention measurements.;Increase in reported self-efficacy verified using The Stroke Self-Efficacy Questionnaire Brazil scale, based on the verification of a variation of at least 15% in pre- and post-intervention measurements. | — |
Countries
Brazil
Contacts
Public ContactLuana Miranda
Hospital das clinicas da faculdade de medicina de Botucatu - HCFMB Unesp
Outcome results
None listed